Steven Barnett
Orthopaedic Surgery · Orange, CANPI 1750378030
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $553,868 of the $796,751 with a category attached, or 69.5%. Depuy Synthes Products, Inc. accounts for 69.6% of it on its own, with 10 other manufacturers making up the rest. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $3390.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$555K
- Omnilife Science, Inc$137K
- Medical Device Business Services, Inc.$55K
- Corin USA$47K
- Zimmer Biomet$2K
- Johnson & Johnson$847
- plus $566 from 5 others
Across 87 payments — averaging $4516.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$344K
- Medical Device Business Services, Inc.$32K
- Omnilife Science, Inc$16K
What the payments were for
- Royalty or licence$553,86870%
- Consulting fees$216,78027%
- Travel & lodging$18,7452%
- Food & beverage$7,2431%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 92 | $554,584 |
| Omnilife Science, Inc | 63 | $136,714 |
| Medical Device Business Services, Inc. | 38 | $54,733 |
| Corin USA | 23 | $46,843 |
| Zimmer Biomet | 3 | $2,464 |
| Johnson & Johnson | 10 | $847 |
| Smith+Nephew | 2 | $248 |
| Pacira Pharmaceuticals Incorporated | 1 | $126 |
| Engage Uni, LLC | 1 | $114 |
| Medacta USA, Inc. | 1 | $59 |
| Nalu Medical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$600,865
- OMNIBotics 3.0$54,306
- Metafix Collared$8,967
- Velys$6,367
- ACTIS$6,253
- PINNACLE$6,143
- NexGen$2,400
- Persona$2,400
- Trifit CF$1,564
- Journey II$135
- Iovera$126
- Engage Partial Knee System$114
- REAL INTELLIGENCE$112
- JOINTPOINT$110
- INHANCE$106
How this compares
$796,751 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $397 |
| Celecoxib | 11 | $300 |
| Methocarbamol | 21 | $229 |
| Amoxicillin | 119 | $211 |
| Oxycodone Hcl | 28 | $194 |
| Diclofenac Sodium | 21 | $142 |
| Baclofen | 18 | $111 |
| Gabapentin | 14 | $84 |
| Clindamycin Hcl | 19 | $69 |
| Meloxicam | 23 | $38 |
| Tramadol Hcl | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Orange
- Robert GorabOrange$13.6M
- Jonah Hebert DaviesOrange$653K
- Bradford HackArcadia$18.3M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.